BioTech_Feed's profile picture. News Portal for BioTech, MedTech, and HealthTech News - Don't Waste your time trying to find Live, Curated, and Searchable News on BioTech + More!

Biotech Feed

@BioTech_Feed

News Portal for BioTech, MedTech, and HealthTech News - Don't Waste your time trying to find Live, Curated, and Searchable News on BioTech + More!

Rising Rate of Drug Shortages Is Framed as a National Security Threat A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals.... openexo.com/feed/item/risi… #BioTech #science

openexo.com

Rising Rate of Drug Shortages Is Framed as a National Security Thre...

A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals.


How 89bios Phase IIb NASH data match up with Akeros in FGF21 class DATA BYTE HOW 89 BIO’S PHASE IIB NASH DATA MATCH UP WITH AKERO’S IN FGF21 CLASSBY Planned Phase III trials would clarify benefit compar... openexo.com/feed/item/how-… #BioTech #science


Genomadix Gets FDA 510(k) Clearance for Point-of-Care PCR System, CYP2C19 Test Formerly known as Spartan Bioscience, Ottawa, Canada-based Genomadix expects to now commercialize the system and test in the US to guid... openexo.com/feed/item/geno… #BioTech #science

openexo.com

Genomadix Gets FDA 510(k) Clearance for Point-of-Care PCR System, C...

Formerly known as Spartan Bioscience, Ottawa, Canada-based Genomadix expects to now commercialize the system and test in the US to guide therapy de...


March 22 Quick Takes: GordonMD,Pfizer Ventures lead Flares $123M B round QUICK TAKES: GORDONMD, PFIZER VENTURES LEAD FLARE’S $123M B ROUND BY Plus: FDA approvals for Cidara, Incyte and updates from Karuna, As... openexo.com/feed/item/marc… #BioTech #science


New CFOs at Remix, Capstan MANAGEMENT TRACKSNEW CFOS AT REMIX, CAPSTANBY Plus: Maderis to be chair at Durect and updates from Generate and Patient Discovery Solut... openexo.com/feed/item/new-… #BioTech #science


Tofersen panel bolsters case for neurofilament as ALS surrogate endpoint REGULATIONTOFERSEN PANEL BOLSTERS CASE FOR NEUROFILAMENT AS ALS SURROGATE ENDPOINT BY FDA advisory committee backs accelerated approval... openexo.com/feed/item/tofe… #BioTech #science


Infusing beans with a new genetic blueprint: Synthetic biology startup engineers soybeans to produce ingredients for cancer drugs, vaccines and infant formula ... openexo.com/feed/item/infu… #BioTech #science


Algae contains high levels of protein and nutrients. Could it help boost food security in the face of climate change? ... openexo.com/feed/item/alga… #BioTech #science


Blood for money: my journey in the industry buying poor Americans plasma The US is one of the few countries that allows donors – who are often struggling economically – to be paid for plasmaI was sitting in t... openexo.com/feed/item/bloo… #BioTech #science

openexo.com

Blood for money: my journey in the industry buying poor Americans p...

The US is one of the few countries that allows donors – who are often struggling economically – to be paid for plasmaI was sitting in the brigh...


Rhisa and Gradient Health data tie-up aims to accelerate innovation Medical technology companies Rhisa and Gradient Health join forces to accelerate healthcare innovation by providing a new scale of dive... openexo.com/feed/item/rhis… #BioTech #science


Human Fasting Modulates Macrophage Function The Journal Club returns on Tuesday 28th March at 12:00 PM Eastern time to the Lifespan.io Facebook channel. This month Dr. Oliver Medv... openexo.com/feed/item/huma… #BioTech #science


Common Genetic Signature May Increase Risk of Multiple Substance Abuse Disorders The results of NIH-funded research suggest that a common genetic signature may increase an individual’s risk of developing substance us... openexo.com/feed/item/comm… #BioTech #science

openexo.com

Common Genetic Signature May Increase Risk of Multiple Substance Ab...

The results of NIH-funded research suggest that a common genetic signature may increase an individual’s risk of developing substance use disorder...


BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for Diabetes BetaLife, a stem cell therapy company working on regenerative medicine for diabetes, acquired the rights to human induced Pluripotent S... openexo.com/feed/item/beta… #BioTech #science

openexo.com

BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for ...

BetaLife, a stem cell therapy company working on regenerative medicine for diabetes, acquired the rights to human induced Pluripotent Stem Cell (iP...


Loading...

Something went wrong.


Something went wrong.